The Indian Immunologicals Ltd (IIL) a wholly owned subsidiary of National Dairy Development Board (NDDB) launched India’s first indigenously developed Hepatitis A vaccine ‘Havisure’ in Hyderabad.
- Havisure vaccine is a two-dose vaccine first dose administered at above 12 months of age and the second at least six months after the first dose.
- The vaccine is recommended for children as part of the routine immunisation as well as for individuals at risk of exposure or travel to the regions with high hepatitis A prevalence.
- In addition to this people with occupational risk of infection and suffering from chronic liver diseases also require Hepatitis A vaccination.
- It is an inflammation of the liver caused by the hepatitis A virus (HAV).
- The virus is primarily spread when an uninfected (and unvaccinated) person ingests food or water that is contaminated with the faeces of an infected person.
- Hepatitis can be an acute (short-term) infection or a chronic (long-term) infection.